JNJ vs LNTH: fair value comparison
Johnson & Johnson and Lantheus Holdings, Inc. · Updated 2026-09-12
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, LNTH currently sits closer to the top of our discount ranking. LNTH carries the stronger quality grade.
| JNJ | LNTH | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $265.58 | $100.88 |
| 12-month range | $185.08–$271.19 | $51.63–$108.96 |
| Sector rank | #108 of 113 Healthcare | #104 of 113 Healthcare |
| Quality grade | C | A |
| Leverage | Moderate | Low |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Fairly Valued | Fairly Valued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: JNJ fair value analysis · LNTH fair value analysis